+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Spine Biologics Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Spine Biologics Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Spine Biologics Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6084275
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Spine Biologics Market grew from USD 3.15 billion in 2024 to USD 3.33 billion in 2025. It is expected to continue growing at a CAGR of 5.28%, reaching USD 4.30 billion by 2030.

The spine biologics sector is undergoing rapid transformation as innovation accelerates the development of advanced graft materials designed to enhance patient outcomes and reduce recovery times. Throughout the value chain, manufacturers are adopting next-generation formulations that combine osteoconductive, osteoinductive, and osteogenic properties in a single product. Clinicians are increasingly favoring minimally invasive techniques that rely on biologics to promote fusion without the need for traditional autograft harvesting, thereby lowering complication rates and shortening hospital stays. At the same time, regulatory bodies have introduced updated guidelines that streamline the approval process for well-characterized bone graft substitutes, encouraging investment in research and development.

As healthcare providers seek cost-effective solutions, payers are scrutinizing clinical evidence to ensure that biologic implants deliver tangible benefits compared to standard of care. This dynamic environment rewards companies that can demonstrate robust real-world performance while maintaining competitive pricing strategies. The following executive summary outlines the most significant shifts in the landscape, the implications of new tariffs, insights drawn from detailed segmentation, regional trends, leading companies’ profiles, and strategic recommendations for industry leaders seeking to navigate this evolving market.

Transformative Shifts in the Spine Biologics Landscape

In recent years, several transformative trends have reshaped the spine biologics landscape. First, the convergence of advanced material science and molecular biology has given rise to composite implants that leverage synthetic bone grafts incorporating calcium phosphate ceramics alongside emerging osteoconductive polymers. Second, the shift toward motion-preserving procedures has elevated the role of non-fusion techniques such as artificial disc replacement and dynamic stabilization, prompting suppliers to tailor biologics for these applications.

Third, as demand for biocomposite matrix solutions grows, manufacturers are increasingly integrating growth factors and peptides to enhance osteoinductive activity and accelerate fusion. Fourth, the growing adoption of minimally invasive surgical approaches, including anterior lumbar interbody fusion and oblique lateral interbody fusion, is driving the need for specialized scaffold geometries and injectable formulations. Finally, heightened scrutiny from payers and regulators is encouraging the standardization of clinical protocols and the generation of real-world evidence, fostering greater transparency and comparability across product offerings. Together, these shifts are redefining competitive advantage and setting a new bar for clinical performance.

Cumulative Impact of United States Tariffs 2025

Effective January 2025, the United States implemented revised tariff schedules on imported biologic implants, raising duties on certain materials used in demineralized bone matrices and select synthetic graft components. These additional levies have increased landed costs for manufacturers relying on overseas production of critical polymers and ceramics. As a result, pricing pressures have intensified across the supply chain, compelling suppliers to explore near-shoring strategies or alternative sourcing partnerships.

The tariff adjustments have also accelerated consolidation among smaller producers, who face margin compression due to higher input costs and limited scale. Larger global players with diversified manufacturing footprints have been better positioned to absorb or offset these levies through operational efficiencies and long-term supplier agreements. Clinicians, in turn, are increasingly aware of the impact on implant pricing, prompting procurement teams to negotiate volume-based discounts or to consider bundled purchasing arrangements. In a landscape punctuated by cost containment mandates, innovation in supply chain optimization will be a critical lever for sustaining growth.

Key Segmentation Insights

A nuanced understanding of product, application, material, end-user, surgical approach, and bone graft type segmentation underscores the market’s complexity. In product type, demineralized bone matrix continues to command a significant share owing to its proven safety profile, while synthetic bone graft offerings-particularly those formulated with calcium phosphate ceramics-are gaining traction for their consistency and off-the-shelf availability. Application segmentation reveals a bifurcation between non-fusion procedures, where artificial disc replacement and dynamic stabilization drive biologics integration, and spinal fusion, with distinct demand for cervical fusion and thoracolumbar fusion interventions.

Material type segmentation highlights the rise of biocomposite matrix systems that combine calcium phosphate and osteoconductive polymers to balance structural strength with bioactivity, alongside a steady niche for xtendofil blocks valued for their handling characteristics. Within the end-user segment, hospitals dominate consumption, with private institutions often leading in early adoption of novel graft technologies compared to their public counterparts. Surgical approach analysis shows that anterior techniques-such as anterior lumbar interbody fusion and oblique lateral interbody fusion-are stimulating demand for injectable or putty-based biologics, while posterior approaches remain foundational for traditional graft placements. Lastly, bone graft type segmentation differentiates allograft demand driven by immunologically inert profiles from autograft usage, where iliac crest bone graft remains the benchmark for osteogenic potency despite donor-site morbidity concerns.

Key Regional Insights

Geographically, the Americas represent a mature market anchored by robust reimbursement frameworks, high procedural volumes, and rapid adoption of minimally invasive spine surgeries. In Europe, Middle East & Africa, fragmented healthcare systems and variable regulatory pathways present both challenges and opportunities, with Western Europe leading in clinical adoption while emerging markets pursue cost-effective bioscaffold solutions. Meanwhile, the Asia-Pacific region is experiencing accelerated growth fueled by rising healthcare expenditure, expanding hospital infrastructure, and increasing awareness of advanced biologic options, particularly in key economies where localized manufacturing drives down prices and accelerates market penetration.

Key Companies Insights

The competitive landscape features a diverse mix of specialized biologics firms, global device manufacturers, and emerging biotech innovators. Alphatec Spine, Inc. and Arthrex Inc. are at the forefront of integrating biologic scaffolds with proprietary instrumentation systems. Aziyo Biologics and Bone Biologics Corp. focus on allograft and composite matrices enhanced by novel sterilization techniques. Baxter International Inc. and Johnson & Johnson Services, Inc. leverage extensive distribution networks to offer a broad portfolio spanning demineralized bone matrices and synthetic ceramics.

Biomatlante SAS and Kuros Biosciences A.G. are pioneering growth factor-loaded carriers, while Camber Spine Technologies, LLC and Spinal Elements, Inc. cater to minimally invasive fusion procedures with injectable formulations. Cerapedics, Inc and ChoiceSpine LLC concentrate on calcium phosphate ceramics with tailored porosity, and CoreLink, LLC by ZAVATION specializes in xtendofil block systems. Globus Medical, Inc. and Medtronic PLC integrate biologics into comprehensive spinal platforms. Induce Biologics USA Inc. and Innovasis, Inc. are advancing tissue-engineered constructs, whereas Life Spine, Inc. and LifeNet Health emphasize donor-derived matrices. Companies such as InVivo Therapeutics Corp. and RTI Surgical, Inc. explore emerging biomaterials, and leading orthopaedic giants like Orthofix Medical Inc., Smith & Nephew PLC, Stryker Corporation, and Zimmer Biomet Holdings, Inc. leverage scale to drive down costs. Other notable players include MTF Biologics, ORHub Inc, Tyber Medical LLC, Xtant Medical Holdings, Inc., and Core industry stalwarts such as Baxter and Arthrex whose growing biologic divisions underscore the sector’s diversification.

Actionable Recommendations for Industry Leaders

To capitalize on evolving market dynamics, industry leaders should prioritize the following actions. First, invest in modular manufacturing capabilities that enable agile scaling of both demineralized and synthetic graft production, mitigating tariff-related supply pressures. Second, establish collaborative partnerships with leading academic centers and surgical key opinion leaders to generate robust real-world evidence demonstrating clinical and economic value across fusion and non-fusion applications. Third, develop targeted formulations for emerging minimally invasive approaches-particularly anterior lumbar and oblique lateral techniques-by optimizing scaffold geometry and delivery mechanisms.

Fourth, enhance value proposition through integrated service offerings, such as bundled implant and biologic packages accompanied by surgeon training programs that accelerate adoption. Fifth, leverage data analytics and digital health platforms to track patient outcomes, inform continuous product improvement, and differentiate on post-market performance. Finally, pursue strategic acquisitions or licensing agreements to fill portfolio gaps-in areas such as growth factor-enriched carriers or xtendofil blocks-thereby delivering comprehensive solutions that address diverse clinical needs.

Conclusion and Strategic Outlook

The spine biologics market stands at an inflection point where material innovations, procedural advancements, and regulatory evolution intersect to redefine care pathways. Companies that strategically align R&D investments with emerging surgical trends, while proactively managing supply-chain challenges, will secure competitive advantage. By cultivating evidence-based differentiation and forging robust partnerships across the healthcare ecosystem, industry participants can deliver superior patient outcomes and sustainable growth. In this dynamic environment, agility, collaboration, and a relentless focus on clinical value will determine which organizations emerge as market leaders.

Market Segmentation & Coverage

This research report categorizes the Spine Biologics Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Demineralized Bone Matrix
  • Synthetic Bone Graft
    • Calcium Phosphate Ceramics
  • Non-Fusion Procedures
    • Artificial Disc Replacement
    • Dynamic Stabilization
  • Spinal Fusion
    • Cervical Fusion
    • Thoracolumbar Fusion
  • Biocomposite Matrix
    • Calcium Phosphate
    • Osteoconductive Polymers
  • Xtendofil Blocks
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Anterior Approach
    • Anterior Lumbar Interbody Fusion
    • Oblique Lateral Interbody Fusion
  • Posterior Approach
  • Allograft
  • Autograft
    • Iliac Crest Bone Graft

This research report categorizes the Spine Biologics Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Spine Biologics Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Alphatec Spine, Inc.
  • Arthrex Inc.
  • Aziyo Biologics
  • Baxter International Inc.
  • Biomatlante SAS
  • Bone Biologics Corp.
  • Camber Spine Technologies, LLC
  • Cerapedics, Inc
  • ChoiceSpine LLC
  • CoreLink, LLC by ZAVATION
  • Globus Medical, Inc.
  • Induce Biologics USA Inc.
  • Innovasis, Inc.
  • Integra LifeSciences Corporation
  • InVivo Therapeutics Corp.
  • Johnson & Johnson Services, Inc.
  • Kuros Biosciences A.G.
  • Life Spine, Inc.
  • LifeNet Health
  • Medtronic PLC
  • MTF Biologics
  • ORHub Inc
  • Orthofix Medical Inc.
  • RTI Surgical, Inc.
  • Smith & Nephew PLC
  • Spinal Elements, Inc.
  • Stryker Corporation
  • Tyber Medical LLC
  • Xtant Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Spine Biologics Market, by Product Type
8.1. Introduction
8.2. Demineralized Bone Matrix
8.3. Synthetic Bone Graft
8.3.1. Calcium Phosphate Ceramics
9. Spine Biologics Market, by Application
9.1. Introduction
9.2. Non-Fusion Procedures
9.2.1. Artificial Disc Replacement
9.2.2. Dynamic Stabilization
9.3. Spinal Fusion
9.3.1. Cervical Fusion
9.3.2. Thoracolumbar Fusion
10. Spine Biologics Market, by Material Type
10.1. Introduction
10.2. Biocomposite Matrix
10.2.1. Calcium Phosphate
10.2.2. Osteoconductive Polymers
10.3. Xtendofil Blocks
11. Spine Biologics Market, by End-User
11.1. Introduction
11.2. Hospitals
11.2.1. Private Hospitals
11.2.2. Public Hospitals
12. Spine Biologics Market, by Surgical Approach
12.1. Introduction
12.2. Anterior Approach
12.2.1. Anterior Lumbar Interbody Fusion
12.2.2. Oblique Lateral Interbody Fusion
12.3. Posterior Approach
13. Spine Biologics Market, by Bone Graft Type
13.1. Introduction
13.2. Allograft
13.3. Autograft
13.3.1. Iliac Crest Bone Graft
14. Americas Spine Biologics Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Spine Biologics Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Spine Biologics Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Alphatec Spine, Inc.
17.3.2. Arthrex Inc.
17.3.3. Aziyo Biologics
17.3.4. Baxter International Inc.
17.3.5. Biomatlante SAS
17.3.6. Bone Biologics Corp.
17.3.7. Camber Spine Technologies, LLC
17.3.8. Cerapedics, Inc
17.3.9. ChoiceSpine LLC
17.3.10. CoreLink, LLC by ZAVATION
17.3.11. Globus Medical, Inc.
17.3.12. Induce Biologics USA Inc.
17.3.13. Innovasis, Inc.
17.3.14. Integra LifeSciences Corporation
17.3.15. InVivo Therapeutics Corp.
17.3.16. Johnson & Johnson Services, Inc.
17.3.17. Kuros Biosciences A.G.
17.3.18. Life Spine, Inc.
17.3.19. LifeNet Health
17.3.20. Medtronic PLC
17.3.21. MTF Biologics
17.3.22. ORHub Inc
17.3.23. Orthofix Medical Inc.
17.3.24. RTI Surgical, Inc.
17.3.25. Smith & Nephew PLC
17.3.26. Spinal Elements, Inc.
17.3.27. Stryker Corporation
17.3.28. Tyber Medical LLC
17.3.29. Xtant Medical Holdings, Inc.
17.3.30. Zimmer Biomet Holdings, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. SPINE BIOLOGICS MARKET MULTI-CURRENCY
FIGURE 2. SPINE BIOLOGICS MARKET MULTI-LANGUAGE
FIGURE 3. SPINE BIOLOGICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SPINE BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. SPINE BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. SPINE BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SPINE BIOLOGICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SPINE BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE CERAMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY ARTIFICIAL DISC REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY DYNAMIC STABILIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY CERVICAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY THORACOLUMBAR FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY OSTEOCONDUCTIVE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY XTENDOFIL BLOCKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR LUMBAR INTERBODY FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY OBLIQUE LATERAL INTERBODY FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY POSTERIOR APPROACH, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY ILIAC CREST BONE GRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 82. CANADA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. CANADA SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 84. CANADA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. CANADA SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 86. CANADA SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 87. CANADA SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 88. CANADA SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 89. CANADA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. CANADA SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 91. CANADA SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 92. CANADA SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 93. CANADA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 94. CANADA SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 95. MEXICO SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. MEXICO SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 97. MEXICO SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. MEXICO SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 99. MEXICO SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 100. MEXICO SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 101. MEXICO SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 102. MEXICO SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. MEXICO SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 105. MEXICO SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 106. MEXICO SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 107. MEXICO SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 138. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 140. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 141. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 142. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 146. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 149. CHINA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. CHINA SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 151. CHINA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. CHINA SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 153. CHINA SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 154. CHINA SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 155. CHINA SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 156. CHINA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. CHINA SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 158. CHINA SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 159. CHINA SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 160. CHINA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 161. CHINA SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 162. INDIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. INDIA SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 164. INDIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. INDIA SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 166. INDIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 167. INDIA SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 168. INDIA SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 169. INDIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. INDIA SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 171. INDIA SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 172. INDIA SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 173. INDIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 174. INDIA SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 175. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 177. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 179. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 180. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 181. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 182. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 184. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 185. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 186. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 187. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 188. JAPAN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. JAPAN SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 190. JAPAN SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. JAPAN SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 192. JAPAN SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 193. JAPAN SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 194. JAPAN SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 195. JAPAN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. JAPAN SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 197. JAPAN SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 198. JAPAN SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 199. JAPAN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 200. JAPAN SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 201. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 203. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 205. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 206. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 207. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 208. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 210. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 211. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 212. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 214. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 216. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 218. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 219. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 220. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 221. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 223. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 224. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 225. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 226. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 227. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 229. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 231. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 232. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 233. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 234. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 236. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 237. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 238. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 239. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 240. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 241. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 242. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 244. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 245. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 246. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 247. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 248. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 249. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 250. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 251. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 252. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 253. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 255. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 257. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 258. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 259. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 260. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 262. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 263. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 264. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 265. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 266. THAILAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. THAILAND SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 268. THAILAND SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. THAILAND SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 270. THAILAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 271. THAILAND SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 272. THAILAND SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 273. THAILAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 274. THAILAND SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 275. THAILAND SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 276. THAILAND SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 277. THAILAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 278. THAILAND SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 279. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 281. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 283. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 284. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 285. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 286. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 287. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 288. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 289. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 290. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 291. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 306. DENMARK SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. DENMARK SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 308. DENMARK SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. DENMARK SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 310. DENMARK SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 311. DENMARK SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 312. DENMARK SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 313. DENMARK SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 314. DENMARK SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 315. DENMARK SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 316. DENMARK SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 317. DENMARK SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 318. DENMARK SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 319. EGYPT SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 320. EGYPT SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 321. EGYPT SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 322. EGYPT SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 323. EGYPT SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 324. EGYPT SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 325. EGYPT SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 326. EGYPT SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 327. EGYPT SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 328. EGYPT SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 329. EGYPT SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 330. EGYPT SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 331. EGYPT SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 332. FINLAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 333. FINLAND SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 334. FINLAND SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 335. FINLAND SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 336. FINLAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 337. FINLAND SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 338. FINLAND SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 339. FINLAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 340. FINLAND SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 341. FINLAND SPINE BIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2030 (USD MILLION)
TABLE 342. FINLAND SPINE BIOLOGICS MARKET SIZE, BY ANTERIOR APPROACH, 2018-2030 (USD MILLION)
TABLE 343. FINLAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT TYPE, 2018-2030 (USD MILLION)
TABLE 344. FINLAND SPINE BIOLOGICS MARKET SIZE, BY AUTOGRAFT, 2018-2030 (USD MILLION)
TABLE 345. FRANCE SPINE BIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 346. FRANCE SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFT, 2018-2030 (USD MILLION)
TABLE 347. FRANCE SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 348. FRANCE SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION PROCEDURES, 2018-2030 (USD MILLION)
TABLE 349. FRANCE SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 350. FRANCE SPINE BIOLOGICS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 351. FRANCE SPINE BIOLOGICS MARKET SIZE, BY BIOCOMPOSITE MATRIX, 2018-2030 (USD MILLION)
TABLE 352. FRANCE SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 353. FRANCE SPINE BIOLOGICS MARKET SIZE, BY

Companies Mentioned

  • Alphatec Spine, Inc.
  • Arthrex Inc.
  • Aziyo Biologics
  • Baxter International Inc.
  • Biomatlante SAS
  • Bone Biologics Corp.
  • Camber Spine Technologies, LLC
  • Cerapedics, Inc
  • ChoiceSpine LLC
  • CoreLink, LLC by ZAVATION
  • Globus Medical, Inc.
  • Induce Biologics USA Inc.
  • Innovasis, Inc.
  • Integra LifeSciences Corporation
  • InVivo Therapeutics Corp.
  • Johnson & Johnson Services, Inc.
  • Kuros Biosciences A.G.
  • Life Spine, Inc.
  • LifeNet Health
  • Medtronic PLC
  • MTF Biologics
  • ORHub Inc
  • Orthofix Medical Inc.
  • RTI Surgical, Inc.
  • Smith & Nephew PLC
  • Spinal Elements, Inc.
  • Stryker Corporation
  • Tyber Medical LLC
  • Xtant Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Spine Biologics Market by Product, Application, End-user - Global Forecast 2025-2030 - Product Image

Spine Biologics Market by Product, Application, End-user - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Spine Biologics Market Size, Share & Trends Analysis Report by Product (Spinal Allografts, Bone Graft Substitutes, Cell-Based Matrix), Surgery, End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Spine Biologics Market Size, Share & Trends Analysis Report by Product (Spinal Allografts, Bone Graft Substitutes, Cell-Based Matrix), Surgery, End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Spine Biologic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Spine Biologic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Spine Biologics Market Report by Product, Surgery Type, End User, and Region 2024-2032 - Product Image

Spine Biologics Market Report by Product, Surgery Type, End User, and Region 2024-2032

  • Report
  • 141 Pages
  • Global
From
Spine Biologics - Global Strategic Business Report - Product Image

Spine Biologics - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.